The antimalarial action of desferal involves a direct access route to erythrocytic (Plasmodium falciparum) parasites.

We designed the N-methylanthranilic-desferrioxamine (MA-DFO) as a fluorescent iron (III) chelator with improved membrane permeation properties. Upon binding of iron (III), MA-DFO fluorescence is quenched, thus allowing traceability of drug-iron (III) interactions. MA-DFO is well tolerated by mammali...

Deskribapen osoa

Xehetasun bibliografikoak

Argitaratua izan da:	J Clin Invest
Egile Nagusiak:	Loyevsky, M, Lytton, S D, Mester, B, Libman, J, Shanzer, A, Cabantchik, Z I
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	American Society for Clinical Investigation 1993
Gaiak:	Research Article
Sarrera elektronikoa:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC330017/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8423220/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116174
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!